跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Zistam-A - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Zistam-A
Approved
STANDARD
Zistam-A
Inventia Healthcare Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1d71466acf3a660c
Company
Inventia Healthcare Ltd.
Type
Standard
Approval Details
Approval Id
1d71466acf3a660c
Drug Approval Philippines Name
Zistam-A
Product Name
Zistam-A
Registration Number
DRP-6452
Brand Name
Zistam-A
Generic Name
Ambroxol Hydrochloride + Levocetirizine Hydrochloride
Dosage Form
Sustained-Release Capsule
Dosage Strength
75mg/5mg
Manufacturer
Inventia Healthcare Ltd.
Importer
I.E. Medica, Inc.
Distributor
I.E. Medica, Inc.
Company Detail Path
/organization/inventia-healthcare-ltd
Issuance Date
13 May 2022
Expiry Date
09 December 2025
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1d71466acf3a660c
Type
Standard
Back to Philippines FDA Approvals